icon-folder.gif   Conference Reports for NATAP  
  EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria
Back grey_arrow_rt.gif
Phase 2 Randomized, Double-Blind Placebo-Controlled Study of Nitazoxanide with Peginterferon Alfa-2a and Ribavirin in Nonresponders with Chronic Hepatitis C Genotype 1: Final Report
  Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
M.L. Shiffman A Ahmed, I.M. Jacobson, R.E, Pruitt, E.B. Keefe, USA